Comprehensive analysis of m6A RNA methylation modification patterns and the immune microenvironment in osteoarthritis

Zhixin Liu1, Heng Liu2,3, Deqiang Li1

  • 1Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, Shandong, China.

Abstract

Insights

This study reveals that m6A RNA methylation modification significantly impacts osteoarthritis (OA) immune regulation. Understanding these mechanisms offers new avenues for precise OA immunotherapy.

Area of Science:

  • Molecular Biology
  • Immunology
  • Genetics

Background:

  • Osteoarthritis (OA) is a prevalent degenerative joint disease lacking effective preventive or curative therapies.
  • The role of m6A RNA methylation modification in OA immune regulation is under investigation.
  • This study aims to elucidate the function of m6A modification in OA pathogenesis.

Purpose of the Study:

  • To comprehensively examine m6A regulators and their modification patterns in OA.
  • To evaluate the impact of these patterns on the OA immune microenvironment.
  • To identify m6A phenotype-related genes and explore their biological functions in OA.

Main Methods:

  • Analysis of m6A regulators in 63 OA and 59 healthy samples.
  • Development of a classifier based on hub m6A regulators to distinguish OA patients.
  • In vitro verification of key m6A regulators' expression and association with immune cells.

Main Results:

  • Differential expression of most m6A regulators observed in OA tissues.
  • A classifier based on six hub m6A regulators effectively distinguished OA patients.
  • Distinct m6A modification patterns correlated with immune cell infiltration, immune responses, and HLA gene expression.
  • Identified 1,592 m6A phenotype-related genes potentially mediating OA synovitis and cartilage degradation via the PI3K-Akt pathway.

Conclusions:

  • m6A RNA methylation modification plays a crucial role in the OA immune microenvironment.
  • The findings provide insights into the regulatory mechanisms of m6A in OA.
  • This research opens new directions for developing precise immunotherapies for osteoarthritis.